Yanzhao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yanzhao Li has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Min Liu
Department of Cell Biology, Third Military Army Medical University, Chongqing 400038, China
2 shared publications- Wen Zeng
Department of Cell Biology, Third Military Medical University, Chongqing, China
2 shared publications Binghan Zou
1 shared publicationChen Zhang
1 shared publication- Chuhong Zhu
Department of Anatomy, Engineering Research Center for Organ Intelligent Biological Manufacturing of Chongqing, key Lab for Biomechanics and Tissue Engineering of Chongqing, Third Military Medical University, Chongqing, 400038, China
1 shared publication Dongcheng Yang
1 shared publication
Latest Publications
- Open Access
- 1 March 2025
- Published by KEAI Publishing in Fundamental Research
- Vol. 5 (2) , 697-714
Macrophage regulation in vascularization upon regeneration and repair of tissue injury and engineered organ transplantation
Tissue engineering and regenerative medicine are effective strategies for the treatment of damaged tissues and end-stage organ failure. Damaged tissue regeneration and organ transplantation require blood vessel reconstruction to facilitate tissue remodeling, the bottleneck for application research in this field. Immune cells are heavily involved in coordinating neovascularization, in which macrophage aggregation is a key factor in angiogenesis and arteriogenesis. Previous studies have promoted tissue vascularization by regulating macrophages; however, the mechanisms underlying macrophage-mediated vascularization remain nebulous. Studies on material-based regulation have primarily been observational and lack systematic and targeted research. Macrophages from different sources exhibit different phenotypes or functions in tissues, such as peripheral blood monocytes and tissue-resident macrophages, with each exhibiting complicated mechanisms for promoting tissue injury and graft remodeling. Therefore, in this review, we discuss the role of different tissue-resident macrophages and circulating monocytes in vascularization during injured tissue regeneration and graft remodeling and summarize the current strategies for the use of biomaterials to regulate macrophages and promote the vascularization of injured tissues and during organ transplantation. A better understanding of these mechanisms will facilitate future tissue engineering research that promotes vascularization by regulating macrophage reactions.
- 1 March 2025
- Published by KEAI Publishing in Fundamental Research
- Vol. 5 (2) , 697-714
Open AccessMacrophage regulation in vascularization upon regeneration and repair of tissue injury and engineered organ transplantation
Tissue engineering and regenerative medicine are effective strategies for the treatment of damaged tissues and end-stage organ failure. Damaged tissue regeneration and organ transplantation require blood vessel reconstruction to facilitate tissue remodeling, the bottleneck for application research in this field. Immune cells are heavily involved in coordinating neovascularization, in which macrophage aggregation is a key factor in angiogenesis and arteriogenesis. Previous studies have promoted tissue vascularization by regulating macrophages; however, the mechanisms underlying macrophage-mediated vascularization remain nebulous. Studies on material-based regulation have primarily been observational and lack systematic and targeted research. Macrophages from different sources exhibit different phenotypes or functions in tissues, such as peripheral blood monocytes and tissue-resident macrophages, with each exhibiting complicated mechanisms for promoting tissue injury and graft remodeling. Therefore, in this review, we discuss the role of different tissue-resident macrophages and circulating monocytes in vascularization during injured tissue regeneration and graft remodeling and summarize the current strategies for the use of biomaterials to regulate macrophages and promote the vascularization of injured tissues and during organ transplantation. A better understanding of these mechanisms will facilitate future tissue engineering research that promotes vascularization by regulating macrophage reactions.
- Open Access
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (29) , eadf7858
Engineered exosomes reprogram Gli1 + cells in vivo to prevent calcification of vascular grafts and autologous pathological vessels
Calcification of autologous pathological vessels and tissue engineering blood vessels (TEBVs) is a thorny problem in clinic. However, there is no effective and noninvasive treatment that is available against the calcification of TEBVs and autologous pathological vessels. Gli1 + cells are progenitors of smooth muscle cells (SMCs) and can differentiate into osteoblast-like cells, leading to vascular calcification. Our results showed that the spatiotemporal distribution of Gli1 + cells in TEBVs was positively correlated with the degree of TEBV calcification. An anticalcification approach was designed consisting of exosomes derived from mesenchymal stem cells delivering lncRNA-ANCR to construct the engineered exosome-Ancr/E7-EXO. The results showed that Ancr/E7-EXO effectively targeted Gli1 + cells, promoting rapid SMC reconstruction and markedly inhibiting Gli1 + cell differentiation into osteoblast-like cells. Moreover, Ancr/E7-EXO significantly inhibited vascular calcification caused by chronic kidney disease. Therefore, Ancr/E7-EXO reprogrammed Gli1 + cells to prevent calcification of vascular graft and autologous pathological vessel, providing unique insights for an effective anticalcification.
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (29) , eadf7858
Open AccessEngineered exosomes reprogram Gli1 + cells in vivo to prevent calcification of vascular grafts and autologous pathological vessels
Calcification of autologous pathological vessels and tissue engineering blood vessels (TEBVs) is a thorny problem in clinic. However, there is no effective and noninvasive treatment that is available against the calcification of TEBVs and autologous pathological vessels. Gli1 + cells are progenitors of smooth muscle cells (SMCs) and can differentiate into osteoblast-like cells, leading to vascular calcification. Our results showed that the spatiotemporal distribution of Gli1 + cells in TEBVs was positively correlated with the degree of TEBV calcification. An anticalcification approach was designed consisting of exosomes derived from mesenchymal stem cells delivering lncRNA-ANCR to construct the engineered exosome-Ancr/E7-EXO. The results showed that Ancr/E7-EXO effectively targeted Gli1 + cells, promoting rapid SMC reconstruction and markedly inhibiting Gli1 + cell differentiation into osteoblast-like cells. Moreover, Ancr/E7-EXO significantly inhibited vascular calcification caused by chronic kidney disease. Therefore, Ancr/E7-EXO reprogrammed Gli1 + cells to prevent calcification of vascular graft and autologous pathological vessel, providing unique insights for an effective anticalcification.
- 18 November 2022
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 144, 31-40
Application of stem cells in engineered vascular graft and vascularized organs
- 18 November 2022
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 144, 31-40
Application of stem cells in engineered vascular graft and vascularized organs
- 1 May 2021
- Published by Wiley in SID Symposium Digest of Technical Papers
- Vol. 52 (1) , 1308-1311
P‐113: Efficiency Enhancement of Quantum dot Light‐Emitting Diodes Via Ligand Exchange
The unique features of solution‐processed quantum dots (QDs) including emission tunability in the visible range, high‐quality saturated color and outstanding intrinsic stability in environment are highly desired in various application fields. Especially, quantum dot light‐emitting diodes (QLEDs) are promising light sources for applications in displays. However, the imbalance injection of holes and electrons have always been a challenging issue of QLED. In this study, the modified ligands which is synthesized by ourselves are incorporated into QDs through solution ligand exchange. The highest occupied molecular orbital (HOMO) of QDs is upshifted from ‐5.65eV to ‐5.35eV, leading to the decrement of the energy gap between the HOMO of QDs and the HOMO of hole transport layer. Through the successful ligands exchange, improvement by factors of 7.5 is achieved in maximum external quantum efficiency (EQE) compared with QLED with OA ligands.
- 1 May 2021
- Published by Wiley in SID Symposium Digest of Technical Papers
- Vol. 52 (1) , 1308-1311
P‐113: Efficiency Enhancement of Quantum dot Light‐Emitting Diodes Via Ligand Exchange
The unique features of solution‐processed quantum dots (QDs) including emission tunability in the visible range, high‐quality saturated color and outstanding intrinsic stability in environment are highly desired in various application fields. Especially, quantum dot light‐emitting diodes (QLEDs) are promising light sources for applications in displays. However, the imbalance injection of holes and electrons have always been a challenging issue of QLED. In this study, the modified ligands which is synthesized by ourselves are incorporated into QDs through solution ligand exchange. The highest occupied molecular orbital (HOMO) of QDs is upshifted from ‐5.65eV to ‐5.35eV, leading to the decrement of the energy gap between the HOMO of QDs and the HOMO of hole transport layer. Through the successful ligands exchange, improvement by factors of 7.5 is achieved in maximum external quantum efficiency (EQE) compared with QLED with OA ligands.